Pacific Edge Ltd

AU:PEB Australia Diagnostics & Research
Market Cap
$104.45 Million
AU$168.68 Million AUD
Market Cap Rank
#18707 Global
#298 in Australia
Share Price
AU$0.17
Change (1 day)
+3.13%
52-Week Range
AU$0.07 - AU$0.22
All Time High
AU$1.54
About

Pacific Edge Limited, a cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic produc… Read more

Pacific Edge Ltd (PEB) - Total Assets

Latest total assets as of September 2025: AU$34.38 Million AUD

Based on the latest financial reports, Pacific Edge Ltd (PEB) holds total assets worth AU$34.38 Million AUD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Pacific Edge Ltd - Total Assets Trend (2005–2025)

This chart illustrates how Pacific Edge Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Pacific Edge Ltd - Asset Composition Analysis

Current Asset Composition (March 2025)

Pacific Edge Ltd's total assets of AU$34.38 Million consist of 83.2% current assets and 16.8% non-current assets.

Asset Category Amount (AUD) % of Total Assets
Cash & Equivalents AU$0.00 61.0%
Accounts Receivable AU$4.97 Million 13.4%
Inventory AU$1.61 Million 4.3%
Property, Plant & Equipment AU$0.00 0.0%
Intangible Assets AU$781.00K 2.1%
Goodwill AU$0.00 0.0%

Asset Composition Trend (2005–2025)

This chart illustrates how Pacific Edge Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Pacific Edge Ltd's current assets represent 83.2% of total assets in 2025, an increase from 20.3% in 2005.
  • Cash Position: Cash and equivalents constituted 61.0% of total assets in 2025, up from 16.5% in 2005.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 45.0% in 2005.
  • Asset Diversification: The largest asset category is accounts receivable at 13.4% of total assets.

Pacific Edge Ltd Competitors by Total Assets

Key competitors of Pacific Edge Ltd based on total assets are shown below.

Company Country Total Assets
ADCNF
OTCGREY:ADCNF
USA $4.51 Billion
Berry Genomics Co Ltd
SHE:000710
China CN¥2.34 Billion
Malaysian Genomics Resource
KLSE:0155
Malaysia RM20.70 Million
NSN Co. Ltd
KQ:031860
Korea ₩60.96 Billion
JOONGANG DNM Co.Ltd
KQ:051980
Korea ₩121.79 Billion
GeneMatrix Inc
KQ:109820
Korea ₩28.03 Billion
Genoray Co. Ltd
KQ:122310
Korea ₩125.67 Billion
Green Cross Lab Cell Corporation
KQ:144510
Korea ₩565.79 Billion

Pacific Edge Ltd - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.09 - 0.59

Moderate asset utilization - Pacific Edge Ltd generates 0.59x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -108.16% - -15.95%

Negative ROA - Pacific Edge Ltd is currently not profitable relative to its asset base.

Pacific Edge Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 4.10 5.26 7.73
Quick Ratio 3.83 5.10 7.54
Cash Ratio 0.00 0.00 0.00
Working Capital AU$22.18 Million AU$ 35.88 Million AU$ 28.29 Million

Pacific Edge Ltd - Advanced Valuation Insights

This section examines the relationship between Pacific Edge Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 7.25
Latest Market Cap to Assets Ratio 2.42
Asset Growth Rate (YoY) -48.1%
Total Assets AU$37.03 Million
Market Capitalization $89.67 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Pacific Edge Ltd's assets at a significant premium ( 2.42x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: Pacific Edge Ltd's assets decreased by 48.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Pacific Edge Ltd (2005–2025)

The table below shows the annual total assets of Pacific Edge Ltd from 2005 to 2025.

Year Total Assets Change
2025-03-31 AU$37.03 Million -48.10%
2024-03-31 AU$71.35 Million -26.53%
2023-03-31 AU$97.12 Million -21.69%
2022-03-31 AU$124.03 Million +297.72%
2021-03-31 AU$31.18 Million +61.34%
2020-03-31 AU$19.33 Million +16.67%
2019-03-31 AU$16.57 Million -15.76%
2018-03-31 AU$19.66 Million -16.54%
2017-03-31 AU$23.56 Million -27.12%
2016-03-31 AU$32.33 Million +155.92%
2015-03-31 AU$12.63 Million -44.42%
2014-03-31 AU$22.73 Million +85.97%
2013-03-31 AU$12.22 Million -34.45%
2012-03-31 AU$18.65 Million +465.91%
2011-03-31 AU$3.29 Million +82.95%
2010-03-31 AU$1.80 Million +100.87%
2009-03-31 AU$896.61K -71.79%
2008-03-31 AU$3.18 Million +464.59%
2007-03-31 AU$562.96K -56.52%
2006-03-31 AU$1.29 Million -6.38%
2005-03-31 AU$1.38 Million --